Greenwich LifeSciences Inc. (GLSI): Price and Financial Metrics
GLSI Price/Volume Stats
| Current price | $14.26 | 52-week high | $21.44 |
| Prev. close | $15.65 | 52-week low | $7.58 |
| Day low | $13.78 | Volume | 63,500 |
| Day high | $15.85 | Avg. volume | 46,518 |
| 50-day MA | $14.63 | Dividend yield | N/A |
| 200-day MA | $10.90 | Market Cap | 183.21M |
GLSI Stock Price Chart Interactive Chart >
Greenwich LifeSciences Inc. (GLSI) Company Bio
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Latest GLSI News From Around the Web
Below are the latest news stories about GREENWICH LIFESCIENCES INC that investors may wish to consider to help them evaluate GLSI as an investment opportunity.
Insiders hold 54% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), and they've been buying recentlyKey Insights Greenwich LifeSciences' significant insider ownership suggests inherent interests in company's expansion... |
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to December 31, 2024 which is approximatel |
Greenwich LifeSciences Insiders Added US$653.7k Of Stock To Their HoldingsGenerally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying... |
Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences IncOn September 11, 2023, Snehal Patel, the CEO, CFO, and 10% Owner of Greenwich LifeSciences Inc (NASDAQ:GLSI), purchased 1,000 shares of the company. |
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although... |
GLSI Price Returns
| 1-mo | -18.51% |
| 3-mo | 59.15% |
| 6-mo | 72.43% |
| 1-year | 20.13% |
| 3-year | -57.61% |
| 5-year | N/A |
| YTD | 35.55% |
| 2023 | -30.79% |
| 2022 | -37.53% |
| 2021 | -33.29% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...